欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > GPCR/GProtein > SCH 58261

浏览历史

S80417

SCH 58261

源叶(MedMol) 99%
  • 英文名:
  • SCH 58261
  • 别名:
  • 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine; 2-(Furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine;
  • CAS号:
  • 160098-96-4
  • 分子式:
  • C18H15N7O
  • 分子量:
  • 345.358
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S80417-2mg 99% ¥297.50元 预计交期:2-3天 - - - EA 加入购物车
源叶(MedMol) S80417-5mg 99% ¥430.00元 9 - - - EA 加入购物车
源叶(MedMol) S80417-10mg 99% ¥710.00元 5 - - - EA 加入购物车
源叶(MedMol) S80417-25mg 99% ¥1420.00元 6 - - - EA 加入购物车
源叶(MedMol) S80417-50mg 99% ¥2250.00元 5 - - - EA 加入购物车
源叶(MedMol) S80417-100mg 99% ¥3600.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively
  • 靶点: IC50: 15 nM (A2A receptor);AdenosineReceptor
  • 体外研究:
    SCH 58261 (0 nM–10 µM; 7 days) decreases cell viability in a concentration-dependent in the NSCLC cell line H1975. SCH58261 (25 μM; 72 hours) can inhibit the growth of CAF cells. Cell Viability Assay Cell Line: H1975 cells Concentration: 10 nM-10 µM Incubation Time: 7 days Result: Produced a concentration-dependent decrease in H1975 cell growth. Cell Proliferation Assay Cell Line: CAF cells Concentration: 25 μM Incubation Time: 72 hours Result: Inhibit the growth of CAF1 and CAF2 cells.
  • 体内研究:
    SCH 58261 (2 mg/kg; i.p.; daily; for 20 days) causes a decrease in the tumor burden in a NSCLC mouse model. SCH 58261 (5 mg/kg; i.p.; 3 times; every 3 hours; 10 minutes before haloperidol) partially decreases the haloperidol-induced catalepsy and the increase in the PENK mRNA expression in both dorsolateral and ventrolateral parts of the striatum at all three examined levels. SCH 58261 diminishes the parkinsonian-like muscle rigidity and potentiates the effect of L-DOPA in rat model. Animal Model: 4‒6 weeks old athymic nude mice (NCI) with PC9 cells xenograft Dosage: 2 mg/kg Administration: Intraperitoneal injection; daily; for 20 days Result: Decreased tumor growth.
  • 参考文献:
    1. Zocchi C, et al. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes. Br J Pharmacol. 1996 Apr;117(7):1381-6. 2. Varani K, et al. Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]-CGS 21680 binding. Br J Pharmacol. 1996 Apr;117(8):1693-701. 3. Xi J, et al. Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol. 2009 Nov;47(5):684-90. 4. Kuzumaki N, et al. Multiple analyses of G-protein coupled receptor (GPCR) expression in the development of gefitinib-resistance in transforming non-small-cell lung cancer. PLoS One. 2012;7(10):e44368. 5. Mediavilla-Varela M, et al. Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth. Cancer Biol Ther. 2013 Sep;14(9):860-8. 6. Wardas J, et al. SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum. Brain Res. 2003 Jul 11;977(2):270-7. 7. Wardas J, et al. SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats. Synapse. 2001 Aug;41(2):160-71.
  • 溶解性: soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.896 ml 14.478 ml 28.955 ml
    5 mM 0.579 ml 2.896 ml 5.791 ml
    10 mM 0.29 ml 1.448 ml 2.896 ml
    50 mM 0.058 ml 0.29 ml 0.579 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。